Beijing Beilu Pharmaceutical Co Ltd
SZSE:300016
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
B
|
Beijing Beilu Pharmaceutical Co Ltd
SZSE:300016
|
CN |
|
C
|
Cubic Sensor and Instrument Co Ltd
SSE:688665
|
CN |
|
M
|
Mastech Digital Inc
AMEX:MHH
|
US |
|
C
|
Canvest Environmental Protection Group Company Ltd
HKEX:1381
|
HK |
|
Ming Yuan Cloud Group Holdings Ltd
HKEX:909
|
CN |
Beijing Beilu Pharmaceutical Co Ltd
Beijing Beilu Pharmaceutical Co., Ltd. engages in the research and development, production, and sale of contrast agents, and central nervous system and hypoglycemic drugs. The company is headquartered in Beijing, Beijing and currently employs 905 full-time employees. The company went IPO on 2009-10-30. The Company’s main products include gadopentetate dimeglumine injection, iohexol injection, Iodoparol injection, Iodixanol injection, ferric ammonium citrate effervescent granules, repaglinide tablets, glimepiride tablets, Jiuwei Zhenxin granules, among others. The firm mainly distributes its products in domestic market.
Beijing Beilu Pharmaceutical Co., Ltd. engages in the research and development, production, and sale of contrast agents, and central nervous system and hypoglycemic drugs. The company is headquartered in Beijing, Beijing and currently employs 905 full-time employees. The company went IPO on 2009-10-30. The Company’s main products include gadopentetate dimeglumine injection, iohexol injection, Iodoparol injection, Iodixanol injection, ferric ammonium citrate effervescent granules, repaglinide tablets, glimepiride tablets, Jiuwei Zhenxin granules, among others. The firm mainly distributes its products in domestic market.